Pauline Gareau is the Global CBRN Lead at SERB, a pharmaceutical company specializing in medical countermeasures and the development of antidotes against chemical, biological, radiological, and nuclear (CBRN) threats. She joined SERB in 2020 and brings over 10 years of experience in the pharmaceutical industry, with a background in biotechnology engineering.

Throughout her career, Pauline has led strategic and operational initiatives across Europe and internationally, working closely with multidisciplinary teams to ensure global access to critical emergency treatments.

Her work focuses on improving preparedness and response capabilities by advancing innovative solutions that protect public health during crises.

Pauline is passionate about science-driven impact, promoting both the development of lifesaving therapies and the importance of public health awareness and science education. She believes that strong collaboration between industry, governments, and healthcare systems is essential to address today’s evolving health security challenges.